Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Cytosolic DNA is characteristic of chromosomally unstable metastatic cancer cells, resulting in constitutive activation of the cGAS–STING innate immune pathway. How tumors co-opt inflammatory signaling while evading immune surveillance remains unknown. Here, we show that the ectonucleotidase ENPP1 promotes metastasis by selectively degrading extracellular cGAMP, an immune-stimulatory metabolite whose breakdown products include the immune suppressor adenosine. ENPP1 loss suppresses metastasis, restores tumor immune infiltration, and potentiates response to immune checkpoint blockade in a manner dependent on tumor cGAS and host STING. Conversely, overexpression of wild-type ENPP1, but not an enzymatically weakened mutant, promotes migration and metastasis, in part through the generation of extracellular adenosine, and renders otherwise sensitive tumors completely resistant to immunotherapy. In human cancers, ENPP1 expression correlates with reduced immune cell infiltration, increased metastasis, and resistance to anti–PD-1/PD-L1 treatment. Thus, cGAMP hydrolysis by ENPP1 enables chromosomally unstable tumors to transmute cGAS activation into an immune-suppressive pathway. Significance: Chromosomal instability promotes metastasis by generating chronic tumor inflammation. ENPP1 facilitates metastasis and enables tumor cells to tolerate inflammation by hydrolyzing the immunotransmitter cGAMP, preventing its transfer from cancer cells to immune cells. This article is highlighted in the In This Issue feature, p. 995
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chromosomal instability induces chronic inflammatory signals by constantly activating the cGAS‐STING signaling mechanism, which downstream NF‐κB function and consecutively increases metastatic cancer cell progression [256] (Figure 1).”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [256]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“For pathway enrichment analysis, the DESeq2 R package (45) was used to identify differentially expressed genes between the ENPP1CGAS and ENPP1CGAS groups within the TCGA BRCA cohort.”
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 3×
“The sorted preranked list was run in GSEA with the Hallmark gene set database that was downloaded from the Molecular Signatures Database (46).”
MethodInfluentialRobust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224 · cited 1×
“We segregated 1,079 breast tumors into four subsets based on their relative CGAS and ENPP1 expression levels and used the CIBERSORT method to infer the prevalence of immune cell subsets from tissue expression profiles (34).”
MethodThe Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationTGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400 · cited 1×
“We next analyzed the mRNA expression levels of CGAS and ENPP1 in 228 bladder cancers treated with anti-PD-L1 (aPD-L1) therapy and a smaller cohort of 52 TNBC tumors treated with aPD1 (36,37).”
MethodCyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996 · cited 1×
“Cytosolic dsDNA is sensed by cGAS, which upon binding to its substrate, catalyzes the formation of the cyclic dinucleotide, cGAMP (13).”
BackgroundSTING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576 · cited 1×
“A potent immune-stimulatory molecule, cGAMP promotes inflammatory signaling in a manner dependent on its downstream effector STING (14,15).”
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371 · cited 1×
“Collectively, these findings suggest that in addition to lymphocytes, granulocytic cells may also play a role in restricting metastatic colonization of Enpp1-KO cells, in line with previous reports showing an anti-tumor and pro-inflammatory effect of CD11b+Ly6G+ cells (28-30).”
ResultTumor mutational burden and response rate to PD-1 inhibition
Yarchoan, M., Hopkins, A., & Jaffee, E. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1713444 · Cited by 3,230 · cited 1×
“In line with its role modulating tumor immune responses, we found that ENPP1 expression within a given cancer type negatively correlates with its overall response rate to anti-PD1/PD-L1 therapy (35).”
BackgroundHoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J., Drill, E., Shen, R., Taylor, A. M., Cherniack, A. D., Thorsson, V., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.022 · Cited by 2,546 · cited 1×
“gov/about-data/publications/pancanatlas) (43).”
Self-citation
Cited by
The cGAS–STING pathway and cancer
Samson, N., & Ablasser, A. (2022) · Nature Cancer · doi:10.1038/s43018-022-00468-w · Cited by 668
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Garland, K. M., Sheehy, T. L., & Wilson, J. T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00750 · Cited by 357
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Butterfield, L. H., & Najjar, Y. G. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00973-8 · Cited by 330
“Moreover, Enpp1 -knockout mice have been shown to be more sensitive to immune checkpoint blockade in models of colorectal and breast cancers 47 .”
Non-cell-autonomous cancer progression from chromosomal instability
Li, J., Hubisz, M. J., Earlie, E. M., Duran, M. A., Hong, C., Varela, A. A., Lettera, E., Deyell, M., Tavora, B., Havel, J. J., et al. (2023) · Nature · doi:10.1038/s41586-023-06464-z · Cited by 307
Self-citation
Metadata
- Authors
- Li, J., Duran, M. A., Dhanota, N., Chatila, W. K., Bettigole, S. E., Kwon, J., Sriram, R. K., Humphries, M. P., Salto-Tellez, M., James, J. A., Hanna, M. G., Melms, J. C., Vallabhaneni, S., Litchfield, K., Usaite, I., Biswas, D., Bareja, R., Li, H. W., Martin, M. L., Dorsaint, P., Cavallo, J.-A., Li, P., Pauli, C., Gottesdiener, L., DiPardo, B. J., Hollmann, T. J., Merghoub, T., Wen, H. Y., Reis-Filho, J. S., Riaz, N., Su, S.-S. M., Kalbasi, A., Vasan, N., Powell, S. N., Wolchok, J. D., Elemento, O., Swanton, C., Shoushtari, A. N., Parkes, E. E., Izar, B., & Bakhoum, S. F.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
- 4Volastra Therapeutics Inc., New York, New York.
- Weill Cornell Medicine (US)
- Queen's University Belfast (GB)
- 6Precision Medicine Centre of Excellence, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
- Columbia University Irving Medical Center (US)
- Harvard University (US)
- The Francis Crick Institute (GB)
- 9Columbia Center for Translational Immunology, New York, New York.
- 13Englander Institute for Precision Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
- 14Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
- University Hospital Zurich (CH)
- University of California, Los Angeles (US)
- University of Oxford (GB)
- Corresponding author
- Bakhoum, Samuel F.
- ORCID
- Li, Jun
- Chatila, Walid K.
- Kwon, John
- Humphries, Matthew P.
- James, Jacqueline A.
- Hanna, Matthew G.
- Melms, Johannes C.
- Litchfield, Kevin
- Usaite, Ieva
- Biswas, Dhruva
- Bareja, Rohan
- Li, Hao Wei
- Martin, Maria Laura
- Dorsaint, Princesca
- Pauli, Chantal
- Gottesdiener, Lee
- Hollmann, Travis J.
- Merghoub, Taha
- Wen, Hannah Y.
- Reis-Filho, Jorge S.
- Riaz, Nadeem
- Kalbasi, Anusha
- Vasan, Neil
- Powell, Simon N.
- Wolchok, Jedd D.
- Elemento, Olivier
- Swanton, Charles
- Shoushtari, Alexander N.
- Parkes, Eileen E.
- Izar, Benjamin
- Bakhoum, Samuel F.
- Venue
- Cancer Discovery
- Published
- 2020-12-28
- Volume
- 11
- Issue
- 5
- Pages
- 1212-1227
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC8102348
- OpenAlex
- W3115597636
- Cited by
- 312
- References
- 47
- Citations by year
- 2026: 53 · 2025: 58 · 2024: 71 · 2023: 61 · 2022: 47 · 2021: 22
- FWCI
- 20.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- NIH (DP5OD026395, K08CA222663, U54CA225088)
- NCI (P50CA247749)
- MSKCC (P30-CA008748)
- Burroughs Wellcome Fund Career Award for Medical Scientists Louis V. Gerstner Jr. Scholars Program Herbert Irving Comprehensive Cancer Center (P30CA013696)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- ENPP1, metastasis, immune evasion, cGAS-STING pathway, extracellular adenosine, chromosomal instability, tumor inflammation, immune checkpoint inhibitor resistance, PD-1/PD-L1 blockade, tumor immune infiltration, ectonucleotidases, tumor microenvironment
- MeSH terms
- Animals, Humans, Hydrolysis, Immunotherapy, Mice, Inbred BALB C, Neoplasm Metastasis, Neoplasms, Nucleotides, Cyclic, Tumor Escape, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis. https://app.cochat.ai/papers/10.1158/2159-8290.cd-20-0387
- The paper
- Li, J., Duran, M. A., Dhanota, N., Chatila, W. K., Bettigole, S. E., Kwon, J., Sriram, R. K., Humphries, M. P., Salto-Tellez, M., James, J. A., Hanna, M. G., Melms, J. C., Vallabhaneni, S., Litchfield, K., Usaite, I., Biswas, D., Bareja, R., Li, H. W., Martin, M. L., . . . Bakhoum, S. F. (2021). Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-20-0387
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.